Olympus Future Growth

Future criteria checks 3/6

Olympus is forecast to grow earnings and revenue by 13.7% and 5.6% per annum respectively. EPS is expected to grow by 14.7% per annum. Return on equity is forecast to be 15.7% in 3 years.

Key information

13.7%

Earnings growth rate

14.7%

EPS growth rate

Medical Equipment earnings growth12.7%
Revenue growth rate5.6%
Future return on equity15.7%
Analyst coverage

Good

Last updated16 Dec 2024

Recent future growth updates

Recent updates

Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Nov 15
Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Nov 07
Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

Oct 12
Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Sep 27
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Does Olympus (TSE:7733) Have A Healthy Balance Sheet?

Jul 14
Does Olympus (TSE:7733) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Olympus Corporation (TSE:7733)

Jun 28
Estimating The Fair Value Of Olympus Corporation (TSE:7733)

Slowing Rates Of Return At Olympus (TSE:7733) Leave Little Room For Excitement

Mar 28
Slowing Rates Of Return At Olympus (TSE:7733) Leave Little Room For Excitement

Olympus Corporation's (TSE:7733) Share Price Matching Investor Opinion

Mar 13
Olympus Corporation's (TSE:7733) Share Price Matching Investor Opinion

Earnings and Revenue Growth Forecasts

TSE:7733 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20271,120,793155,630119,508207,61414
3/31/20261,057,019139,844109,514192,56415
3/31/20251,003,698116,75074,190204,99315
9/30/2024973,59587,72681,759147,854N/A
6/30/2024966,04627,88456,269118,734N/A
3/31/2024936,21026,610-22,25942,365N/A
12/31/2023916,09239,468-36,58330,686N/A
9/30/2023901,50756,53411,19580,406N/A
6/30/2023875,586126,381-1,68072,238N/A
3/31/2023881,923137,80927,86798,490N/A
12/31/2022933,645137,62345,131109,416N/A
9/30/2022925,858126,84847,185107,203N/A
6/30/2022891,410121,91260,183119,188N/A
3/31/2022868,867115,742107,958169,729N/A
12/31/2021793,72795,27485,693150,356N/A
9/30/2021774,11398,06390,544155,506N/A
6/30/2021785,41184,46778,484139,415N/A
3/31/2021730,54465,59964,895124,122N/A
12/31/2020715,92446,44355,563116,827N/A
9/30/2020724,72241,45942,698103,723N/A
6/30/2020752,17642,85550,303113,526N/A
3/31/2020797,41151,67067,615133,544N/A
12/31/2019807,88760,75872,843136,095N/A
9/30/2019801,20249,70444,493106,769N/A
6/30/2019795,19333,4698,58670,321N/A
3/31/2019793,8628,1475,47766,943N/A
12/31/2018795,47915,5549,62371,514N/A
9/30/2018798,91521,73215,84379,978N/A
6/30/2018795,20530,324N/A100,036N/A
3/31/2018786,49757,064N/A95,146N/A
12/31/2017786,60885,083N/AN/AN/A
9/30/2017767,50885,830N/A91,430N/A
6/30/2017751,45879,716N/AN/AN/A
3/31/2017748,05078,191N/A90,194N/A
12/31/2016745,54360,888N/AN/AN/A
9/30/2016758,77748,983N/A35,146N/A
6/30/2016785,44454,390N/AN/AN/A
3/31/2016804,57862,594N/A48,621N/A
12/31/2015807,1972,188N/AN/AN/A
9/30/2015805,4324,742N/A92,093N/A
6/30/2015785,230-144N/AN/AN/A
3/31/2015764,671-8,737N/A66,811N/A
12/31/2014749,62739,710N/AN/AN/A
9/30/2014734,46943,896N/A72,544N/A
6/30/2014721,07023,599N/AN/AN/A
3/31/2014713,28613,627N/A72,388N/A
12/31/2013696,2976,239N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7733's forecast earnings growth (13.7% per year) is above the savings rate (0.3%).

Earnings vs Market: 7733's earnings (13.7% per year) are forecast to grow faster than the JP market (7.9% per year).

High Growth Earnings: 7733's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7733's revenue (5.6% per year) is forecast to grow faster than the JP market (4.2% per year).

High Growth Revenue: 7733's revenue (5.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7733's Return on Equity is forecast to be low in 3 years time (15.7%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 08:59
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Olympus Corporation is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Kunihiko KannoBNP Paribas Securities (Asia)